HIV/AIDS prevalence testing - Merits, methodology and outcomes of a survey conducted at a large mining organisation in South Africa

South African Medical Journal

Volumn 96, Issue 2, 2006, Pages 134-139

  Stevens, Wendy ^a   Apostolellis, A ^a   Napier, G ^a   Scott, L ^a   Gresak, G ^b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b Anglo Platinum South Africa   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE DISTRIBUTION; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE SURVEILLANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GEOGRAPHIC DISTRIBUTION; GROUPS BY AGE; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MINING; OCCUPATIONAL HEALTH; POPULATION DISTRIBUTION; PREVALENCE; RESOURCE ALLOCATION; SAMPLE SIZE; SOUTH AFRICA; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIV; HIV ANTIBODIES; HIV SEROPREVALENCE; HUMANS; MINING; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; SOUTH AFRICA;

EID: 33144488819     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Statistics South Africa. Mid-year Population Estimates 2004. Statistical release P0302. Pretoria: Statistics South Africa, 2004.
2. AIDS Epidemic Update: December 2003, UNAIDS/WHO. http://www.unaids.org/en/geographical+area
3. Department of Health. National HIV and Syphilis Antenatal Sero-Prevalence Survey in South Africa: 2003. Pretoria: DOH, 2003. http://www.doh.gov.za/docs/pr/2003/pr0703.html
4. Statistics South Africa. State of the World Population: 2004. http://www.statssa.gov.za/news_archive/17sep2004_1.asp
5. Doyle PR. The impact of AIDS on the South African population. Part 1. In: AIDS in South Africa: The Demographic and Economic Implications. Paper No. 23. Johannesburg: Centre for Health Policy, Department of Community Health, University of the Witwatersrand, 1991.
6. Boisson E, Nicoll A, Zaba B, Rodrigues LC. Interpreting HIV seroprevalence data from pregnant women. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 15: 434-439.
7. Hunter SC, Isingo R, Boerma JT, Urassa M, Mwaluko GM, Zaba B. The association between HIV and fertility in a cohort study in rural Tanzania. J Biosoc Sci 2003; 35: 189-199.
8. Shisana O, Simbayi LC, eds. Nelson Mandela/HSRC Study of HIV/AIDS: South African National HIV Prevalence, Behavioural Risks and Mass Media: Household Survey 2002. Cape Town: Human Sciences Research Council, 2002.
9. Johnson L, Budlender D. HIV risk factor: A review of the demographic, socio-economic, biomedical and behavioural determinants of HIV prevalence in South Africa. CARE Monograph 2002; No. 8.
10. Rosen S, Vincent JR, MacLeod W, Fox H, Thea DM, Simon JL. The cost of HIV/AIDS to businesses in southern Africa. AIDS 2004; 18: 317-324.
11. Evian C, Fox M, MacLeod W, Slotow SJ, Rosen S. Prevalence of HIV in workforces in Southern Africa, 2000 - 2001. S Afr Med J 2004; 94: 125-130.
12. Corbett EL, Charalambous S, Moloi VM, et al. Human immunodeficiency virus and the prevalence of undiagnosed tuberculosis in African gold miners. Am J Respir Crit Care Med 2004; 170: 673-679.
13. Heywood MJ. HIV testing in the workplace: clarifying the meaning of South Africa's Employment Equity Act. AIDS Analysis Africa 2000; 10: 13-14.
14. Spielberg F, Branson BM, Goldbaum GM, et al. Choosing HIV counseling and testing strategies for outreach settings: A randomized trial. J Acquir Immune Defic Syndr Hum Retrovirol 2005; 38: 348-355.
15. FDA notifications. Oral fluid-based rapid HIV test approved. AIDS Alert 2004; 19: 71-72.
16. Hodinka RL, Nagashunmugam T, Malamud D. Detection of human immunodeficiency virus antibodies in oral fluids. Clin Diagn Lab Immunol 1998; 5: 419-426.
17. Luo N, Kasolo F, Ngwenya BK, du Pont HL, Zumla A. Use of saliva as an alternative to serum for HIV screening in Africa. S Afr Med J 1995; 85: 156-157.
18. Gershy-Damet GM, Koffi K, Abouya L, et al. Salivary and urinary diagnosis of human immunodeficiency viruses 1 and 2 infection its Cote d'Ivoire, using two assays. Trans R Soc Trop Med Hyg 1995; 86: 670-671.
19. Chassany O, Bergmann JF, Mazeron MC, et al. Testing of anti-HIV antibodies in saliva. AIDS 1994; 8: 713-714.
20. Granade TC, Phillips SK, Parekh B, et al. Detection of antibodies to HIV-1 in oral fluids: A large-scale evaluation of immunoassay performance. Clin Diagn Lab Immunol 1998; 5: 171-173.
21. Dickson NP, Austin FJ, Paul C, Sharples KJ, Skegg DC. HIV surveillance by testing saliva from injecting drug users: a national study in New Zealand. J Epidemiol Community Health 1994; 48(1): 55-57.
22. Frerichs RR, Htoon MT, Eskes N, Lwin S. Comparison of saliva and serum for HIV surveillance in developing countries. Lancet 1992; 340: 1496-1499.
23. Granade TC, Phillips SE, Parekh B, Pau CP, George JR. Oral fluid as a specimen for detection and confirmation of antibodies to human immunodeficiency virus type 1. Clin Diagn Lab Immunol 1995; 2: 395-399.
24. Mason B. SA's workplace programmes still poor, study finds. AIDS Analysis Africa 1995; 5: 15.